retatrutide tesamorelin ipamorelin Peptide & Metabolic Therapy: What

Common (typically mild and transient): Increased appetite (moderate, less than GHRP-6) Flushing and warmth at the injection site or face Transient drowsiness or sleepiness, particularly with evening doses Mild water retention and peripheral edema Increased gastrointestinal motility Less Common: Elevations in cortisol and ACTH (moderate, comparable to hCRH) Mild prolactin elevation (less than TRH-induced levels) Numbness or tingling in extremities Joint stiffness Lightheadedness post-injection Rare or Theoretical Concerns: Impaired glucose metabolism and elevated blood glucose with prolonged use Potential tachyphylaxis (reduced response) with continuous daily dosing Theoretical promotion of existing malignancies through elevated GH/IGF-1 (applies to all GH-elevating compounds) Side effect incidence tends to be lower than with exogenous hGH because GHRP-2 stimulates endogenous GH synthesis within physiological regulatory limits

Please refer to your tests specific Test Preparation and Instructions for more information regarding the potential effects of medications, foods, and supplements on this test

Injections are simple, using a small insulin-type syringe, and most patients quickly become comfortable with the process

Castegna, A

Lack of Medical Oversight: A qualified professional, like our licensed nurses, does more than just inject